Experimental Biological/Vaccine,Experimental Biological/Vaccine,Active Comparator Biological/Vaccine
Sponsors
BioNet-Asia Co., Ltd. 19 Soi Udomsuk 37, Sukhumvit 103 Rd., Prakanong, Bangkok 10260 Thailand, BioNet-Asia Co., Ltd. 19 Soi Udomsuk 37, Sukhumvit 103 Road, Prakanong, Bangkok 10260, Thailand, Chulalongkorn University, BioNet-Asia Co., Ltd., Liaoning Cheng Biotechnology, Shenyang
Conditions
Healthy children
Japanese encephalitis
Japanese encephalitis vaccine
Immunogenicity
Booster
Inactivated JE vaccineParticipants who recovered from COVID-19
COVID-19 Vaccine
SARS-CoV-2
Antibody
Cellular immunity
Post COVID-19
intramuscular
intradermalPertussis
PertussisPertussis
Whooping cough
acellular Pertussis
TdaPPertussis
acellular pertussis vaccine (aP) and Tetanus Toxoid,Pertussis, Whooping cough
Pertussis, Whooping coughPrevention of COVID-19 with SARS-CoV-2 mRNA vaccine platform, comparing the number of doses and interval after infection, in healthy Thai children aged 6 months to 4 years.
SARS-CoV-2, mRNA vaccine, COVID-19 vaccine, Child, Infant, Immunogenicity, Reactogenicity
Phase 1
A phase I/II randomized, observer-blind, controlled study to assess safety and immunogenicity of acellular Pertussis vaccine given alone or in combination with Tetanus-diphtheria vaccine in healthy adults aged 18-35 years
Active, not recruitingTCTR20140703001
Start: 2014-06-28Updated: 2026-03-30
Immunogenicity and Safety of recombinant acellular pertusis-containing vaccine (TdaP) and a pedriatric recombinant acellular pertussis-containing vaccine (DTaP) in healthy children
Active, not recruitingTCTR20190201001
Start: 2019-07-01Target: 140Updated: 2026-03-30
Phase 2
A phase II/III randomized, observer-blind, controlled study to demonstrate non-inferior immunogenicity of a combined Tetanus-diphtheria-acellular Pertussis vaccine as compared to Adacel® vaccine in healthy subjects aged 12-17 years
Active, not recruitingTCTR20150703002
Start: 2015-07-06Updated: 2026-03-30
Immunogenicity of various recombinant acellular pertussis-containing vaccines in healthy adolescents
Active, not recruitingTCTR20181031001
Start: 2019-05-22Target: 450Updated: 2026-03-30
ChAdOx1 Vaccine Dose-Sparing Strategies in Post COVID-19 patients: A Randomized Controlled Trial
Active, not recruitingTCTR20211004005
Start: 2022-08-01Target: 360Updated: 2026-03-30
Safety and Immunogenicity of mRNA SARS-CoV-2 vaccine in healthy Thai children aged 6 months-4 years with or without previous SARS-CoV-2 infection (COVID-19)
Active, not recruitingTCTR20220927003
Start: 2022-10-29Target: 120Updated: 2026-03-30